Nichols Alexander Julian 4

What Happened Nichols Alexander Julian, enGene Holdings Inc.'s Chief Strategy & Operations Officer, received a grant of 195,000 derivative securities (reported as an "A" award) on January 30, 2026. The filing reports an acquisition price of $0.00, indicating no cash paid at grant. The award is subject to vesting (see footnote).

Key Details

• Transaction date: 2026-01-30; Form 4 filed: 2026-02-03 (timely).
• Reported amount: 195,000 derivative shares; reported price: $0.00; total reported cash value: $0.
• Vesting: This award vests monthly in substantially equal amounts over 48 months, subject to continued service (Footnote F1).
• Transaction code: A (grant/award). No 10b5-1 plan, tax withholding, or post-transaction holdings were specified in the provided filing.
• Accession #: 0000929638-26-000482 (for reference).

Context This transaction is a compensation-related award (derivative securities) rather than an open-market purchase or sale. Such grants are commonly used for incentive compensation and do not necessarily reflect an insider's view on the stock; they generally vest over time to encourage retention.